Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Innovations in CKRT: individualized therapy with fewer complications

Nature Reviews Nephrology volume 16, pages 560–561 (2020)Cite this article

Subjects

Continuous kidney replacement therapy (CKRT) can be a lifesaving intervention for critically ill patients; however, mortality remains high. The adaptation of existing innovations, including anti-clotting measures; cloud-computing for optimized treatment prescribing and therapy monitoring; and real-time sensing of blood and/or filter effluent composition to CKRT devices has the potential to enable personalized care and improve the safety and efficacy of this therapy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Broman, M. E. et al. Endotoxin and cytokine reducing properties of the oXiris membrane in patients with septic shock: a randomized crossover double-blind study. PLoS ONE 14, e0220444 (2019).

    Article  CAS  Google Scholar 

  2. Tumlin, J. A. et al. A multi-center, randomized, controlled, pivotal study to assess the safety and efficacy of a selective cytopheretic device in patients with acute kidney injury. PLoS ONE 10, e0132482 (2015).

    Article  Google Scholar 

  3. Szamosfalvi, B., Frinak, S. & Yee, J. Automated regional citrate anticoagulation: technological barriers and possible solutions. Blood Purif. 29, 204–209 (2010).

    Article  Google Scholar 

  4. Szamosfalvi, B., Frinak, S. & Yee, J. Sensors and hybrid therapies: a new approach with automated citrate anticoagulation. Blood Purif. 34, 80–87 (2012).

    Article  CAS  Google Scholar 

  5. Roth, A. et al. Infrared spectroscopy in hemodialysis: reagent-free monitoring of patient detoxification by infrared spectroscopy. Anal. Bioanal. Chem. 403, 391–399 (2012).

    Article  CAS  Google Scholar 

  6. Sharma, M. K. et al. On-line monitoring of electrolytes in hemodialysis: on the road towards individualizing treatment. Expert Rev. Med. Devices 13, 933–943 (2016).

    Article  CAS  Google Scholar 

  7. Daugirdas, J. T. & Tattersall, J. E. Automated monitoring of hemodialysis adequacy by dialysis machines: potential benefits to patients and cost savings. Kidney Int. 78, 833–835 (2010).

    Article  Google Scholar 

  8. Shieh, J. J. et al. Characterization of MB-102, a new fluorescent tracer agent for point-of-care renal function monitoring. J. Pharm. Sci. 109, 1191–1198 (2020).

    Article  CAS  Google Scholar 

  9. Yessayan, L., Friank, S. & Szamosfalvi, B. Online hemoglobin and oxygen saturation sensing during continuous renal replacement therapy with regional citrate anticoagulation. ASAIO J. 61, 489–495 (2015).

    Article  CAS  Google Scholar 

  10. Shu, F. et al. Multimodal flow visualization and optimization of pneumatic blood pump for sorbent hemodialysis system. Artif. Organs 33, 334–345 (2009).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, University of Michigan, Ann Arbor, MI, USA

    Balazs Szamosfalvi & Lenar Yessayan

Authors
  1. Balazs Szamosfalvi
    View author publications

    Search author on:PubMed Google Scholar

  2. Lenar Yessayan
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Balazs Szamosfalvi.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Szamosfalvi, B., Yessayan, L. Innovations in CKRT: individualized therapy with fewer complications. Nat Rev Nephrol 16, 560–561 (2020). https://doi.org/10.1038/s41581-020-0326-1

Download citation

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41581-020-0326-1

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing